They dont expect a decision before the 4th Qtr. You are correct Sir.I read it quickly and wrong- so decision might still occur sometime in the 4th quarter, but they must get that advisory meeting confirmed and scheduled in for October so FDA approval decision can move forward before end of 2012./.
You forgot to mention that the European Commission’s decision on teduglutide is expected around the end of August 2012 and that the company has received a tentative date for an advisory committee meeting on Gattex from the FDA.
Like I have been saying, its either a 3 month PDUFA delay with Advisory meeting in October,, OR a fair possibility company has some idea they will be receiving a CRL. Either one will occur, nothing more. Current PDUFA date is obviously a no go..